Imipramine-induced c-fos expression in the medial prefrontal cortex is decreased in the ACTH-treated rats

Journal of Biochemical and Molecular Toxicology

Volumn 27, Issue 11, 2013, Pages 486-491

  Li, Bingjin ^a,c   Suemaru, Katsuya ^b,c   Kitamura, Yoshihisa ^d   Gomita, Yutaka ^b   Araki, Hiroaki ^c   Cui, Ranji ^a,c  

^a NORTHEAST NORMAL UNIVERSITY   (China)

^b SHUJITSU UNIVERSITY   (Japan)

^c EHIME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d OKAYAMA UNIVERSITY   (Japan)

Author keywords

Cell, c Fos; Depression; Medial Prefrontal cCrtex

Indexed keywords

CORTICOTROPIN; IMIPRAMINE; SODIUM CHLORIDE; TETRACOSACTIDE ZINC PHOSPHATE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CENTRAL NUCLEUS (AMYGDALA); CONCENTRATION (PARAMETERS); DENTATE GYRUS; DRUG DETERMINATION; DRUG EFFECT; GENE EXPRESSION; HIPPOCAMPUS; IMMUNOREACTIVITY; MALE; NONHUMAN; ONCOGENE C FOS; PREFRONTAL CORTEX; RAT; TREATMENT DURATION; TREATMENT RESISTANT DEPRESSION;

RATTUS;

CELL, C-FOS; DEPRESSION; MEDIAL PREFRONTAL CCRTEX;

ADRENOCORTICOTROPIC HORMONE; AMYGDALA; ANIMALS; ANTIDEPRESSIVE AGENTS, TRICYCLIC; DENTATE GYRUS; DEPRESSION; GENE EXPRESSION REGULATION; IMIPRAMINE; PREFRONTAL CORTEX; PROTO-ONCOGENE PROTEINS C-FOS; RATS;

EID: 84887021938     PISSN: 10956670     EISSN: 10990461     Source Type: Journal    
DOI: 10.1002/jbt.21510     Document Type: Article

References (35)

1. Arana GW, Wilens TE, Baldessarini RJ. Plasma corticosterone and cortisol following dexamethasone in psychiatric patients. Psychoneuroendocrinology 1985;10:49-60.
2. Hill MN, McLaughlin RJ, Pan B, Fitzgerald ML, Roberts CJ, Lee TT, Karatsoreos IN, Mackie K, Viau V, Pickel VM, McEwen BS, Liu QS, Gorzalka BB, Hillard CJ. Recruitment of prefrontal cortical endocannabinoid signaling by glucocorticoids contributes to termination of the stress response. J Neurosci 2011;31:10506-10515
3. Carroll BJ, Greden JF, Feinberg M, Lohr N, James NM, Steiner M, Haskett RF, Albala AA, DeVigne JP, Tarika J. Neuroendocrine evaluation of depression in borderline patients. Psychiatr Clin North Am 1981;4:89-99.
4. Bauer ME, Papadopoulos A, Poon L, Perks P, Lightman SL, Checkley S, Shanks N. Altered glucocorticoid immunoregulation in treatment resistant depression. Psychoneuroendocrinology 2003;28:49-65.
5. Murphy BE, Dhar V, Ghadirian AM, Chouinard G, Keller R. Response to steroid suppression in major depression resistant to antidepressant therapy. J Clin Psychopharmacol 1991;11:121-126.
6. Greden JF, Gardner R, King D, Grunhaus L, Carroll BJ, Kronfol Z. Dexamethasone suppression tests in antidepressant treatment of melancholia. The process of normalization and test-retest reproducibility. Arch Gen Psychiatry 1983;40:493-500.
7. Barden N, Reul JM, Holsboer F. Do antidepressants stabilize mood through actions on the hypothalamic-pituitary-adrenocortical system? Trends Neurosci 1995;18:6-11.
8. Sonino N, Boscaro M, Ambroso G, Merola G, Mantero F. Prolonged treatment of Cushing's disease with metyrapone and aminoglutethimide. IRCS Med Sci 1986;14:485-486.
9. Kitamura Y, Araki H, Gomita Y. Influence of ACTH on the effects of imipramine, desipramine and lithium on duration of immobility of rats in the forced swim test. Pharmacol Biochem Behav 2002;71:63-69.
10. 2A receptor in ACTH-treated rats. Pharmacol Biochem Behav 2002;72:397-402.
11. Shikanai H, Yoshida T, Konno K, Yamasaki M, Izumi T, Ohmura Y, Watanabe M, Yoshioka M. Distinct neurochemical and functional properties of GAD67-containing 5-HT neurons in the rat dorsal raphe nucleus. J Neurosci 2012;32:14415-14426.
12. Morinobu S, Strausbaugh H, Terwilliger R, Duman RS. Regulation of c-Fos and NGF1-A by antidepressant treatments. Synapse 1997;25:30.
13. Magarinos AM, McEwen BS. Stress-induced atrophy of apical dendrites of hipppocampal CA3c neurons: comparison of stressors. Neuroscience 1995;69:83-88.
14. Liu L, Li B, Zhou Y, Wang L, Tang F, Shao D, Jiang X, Zhao H, Cui R, Li Y. Antidepressant-like effect of fuzi total alkaloid on ovariectomized mice. J Pharmacol Sci 2012;120:280-287.
15. McEwen BS. Allostasis and allostatic load: implications for neuropsychopharmacology. Neuropsychopharmacology 2000;22:108-124.
16. Drevets WC. Neuroimaging abnormalities in the amygdala in mood disorders. Ann N Y Acad Sci 2003;985:420-444.
17. Anand A, Shekhar A. Brain imaging studies in mood and anxiety disorders: special emphasis on the amygdala. Ann N Y Acad Sci 2003; 985:370-388.
18. Merriam EP, Thase ME, Haas GL, Keshavan MS, Sweeney JA. Prefrontal cortical dysfunction in depression determined by Wisconsin Card Sorting Test performance. Am J Psychiatry 1999;156:780-782.
19. Hornig M, Mozley PD, Amsterdam JD. HMPAO SPECT brain imaging in treatment-resistant depression. Prog Neuropsychopharmacol Biol Psychiatry 1997;21:1097-1114.
20. Morelli M, Pinna A. Antidepressants and atypical neuroleptics induce Fos-like immunoreactivity in the central extended amygdala. Ann N Y Acad Sci 1999;877:703-706.
21. Miyata S, Hamamura T, Lee Y, Miki M, Habara T, Oka T, Endo S, Taoka H, Kuroda S. Contrasting Fos expression induced by acute reboxetine and fluoxetine in the rat forebrain: neuroanatomical substrates for the antidepressant effect. Psychopharmacology (Berl) 2005;177:289-295.
22. Yoo SD, Holladay JW, Fincher TK, Dewey MJ. Rapid microsample analysis of imipramine and desipramine by reversed-phase high-performance liquid chromatography with ultraviolet detection. J Chromatogr B Biomed Appl 1995;668:338-42.
23. Lim H, Park H, Kim HP. Effects of flavonoids on matrix metalloproteinase-13 expression of interleukin-1β-treated articular chondrocytes and their cellular mechanisms: inhibition of c-Fos/AP-1 and JAK/STAT signaling pathways. J Pharmacol Sci 2011;116:221-231.
24. Jin C, Araki H, Nagata M, Suemaru K, Shibata K, Kawasaki H, Hamamura T, Gomita Y. Withdrawal-induced c-Fos expression in the rat centromedial amygdala 24 h following a single morphine exposure. Psychopharmacology (Berl) 2004;175:428-435.
25. Diorio D, Viau V, Meaney MJ. The role of the medial prefrontal cortex (cingulate cortex) in the regulation of hypothalamic-pituitaryadrenal responses to stress. J Neurosci 1993;13:3839-3847.
26. McEwen AM, Burgess DT, Hanstock CC. Increased glutamate levels in the medial prefrontal cortex in patients with postpartum depression. Neuropsychopharmacology 2012;37:2428-2435.
27. 2A receptor agonists into the medial prefrontal cortex produces a head-twitch response in rats. J Pharmacol Exp Ther 1997;282:699-706.
28. Barnes NM, Sharp T. A review of central 5-HT receptors and their function. Neuropharmacology 1999;38:1083-1152.
29. Bergstrom DA, Kellar KJ. Adrenergic and serotonergic receptor binding in rat brain after chronic desmethylimipramine treatment. J Pharmacol Exp Ther 1979;209:256-261.
30. Dumbrille-Ross A, Tang SW, Coscina DV. Lack of effect of raphe lesions on serotonin S2 receptor changes induced by amitriptyline and desmethylimipramine. Psychiatry Res 1982;7:145-151.
31. 2) and beta-adrenergic receptors in rat cerebral cortex following novel and classical antidepressant treatment. J Psychiatry Neurosci 1991;16:209-214.
32. 2 receptor-mediated wet-dog shake behaviors. Psychopharmacology (Berl) 1992;108:27-32.
33. Prewitt CM, Herman JP. Lesion of the central nucleus of the amygdala decreases basal CRH mRNA expression and stress-induced ACTH release. Ann N Y Acad Sci 1994;746;438-440.
34. Beck CH. Acute treatment with antidepressant drugs selectively increases the expression of c-fos in the rat brain. J Psychiatry Neurosci 1995;20:25-32.
35. Morelli M, Pinna A, Ruiu S, Del Zompo M. Induction of Fos-like-immunoreactivity in the central extended amygdala by antidepressant drugs. Synapse 1999;31:1-4.